We have shown that the Na/K-ATPase and Src form a signaling receptor complex. Here we determined how alterations in the amount and properties of the Na/K-ATPase affect basal Src activity and ouabain-induced signal transduction. Several ␣1 subunit knockdown cell lines were generated by transfecting LLC-PK1 cells with a vector expressing ␣1-specific small interference RNA. Although the ␣1 knockdown resulted in significant decreases in Na/K-ATPase activity, it increased the basal Src activity and tyrosine phosphorylation of focal adhesion kinase, a Src effector. Concomitantly it also abolished ouabaininduced activation of Src and ERK1/2. When the knockdown cells were rescued by a rat ␣1, both Na/K-ATPase activity and the basal Src activity were restored. In addition, ouabain was able to stimulate Src and ERK1/2 in the rescued cells at a much higher concentration, consistent with the established differences in ouabain sensitivity between pig and rat ␣1. Finally both fluorescence resonance energy transfer analysis and co-immunoprecipitation assay indicated that the pumping-null rat ␣1 (D371E) mutant could also bind Src. Expression of this mutant restored the basal Src activity and focal adhesion kinase tyrosine phosphorylation. Taken together, the new findings suggest that LLC-PK1 cells contain a pool of Src-interacting Na/K-ATPase that not only regulates Src activity but also serves as a receptor for ouabain to activate protein kinases. Na/K-ATPase was discovered by Skou (1) as the molecular machinery of the cellular sodium pump. It belongs to a family of evolutionarily ancient ATPases that couple the hydrolysis of ATP to membrane ion translocation (2, 3). A major difference between the Na/K-ATPase and other ATPases is its ability to bind cardiotonic steroids such as ouabain. Studies from many laboratories have now established that the binding of ouabain to this enzyme not only inhibits the ATPase activity but also stimulates protein tyrosine kinases such as Src (4, 5). The activated Src in turn transactivates epidermal growth factor receptor, resulting in the assembly and activation of multiple signaling cascades such as the ERK1/2 2 and phospholipase C-␥/ protein kinase C pathways (5, 6).
Na/K-ATPase was discovered by Skou (1) as the molecular machinery of the cellular sodium pump. It belongs to a family of evolutionarily ancient ATPases that couple the hydrolysis of ATP to membrane ion translocation (2, 3) . A major difference between the Na/K-ATPase and other ATPases is its ability to bind cardiotonic steroids such as ouabain. Studies from many laboratories have now established that the binding of ouabain to this enzyme not only inhibits the ATPase activity but also stimulates protein tyrosine kinases such as Src (4, 5) . The activated Src in turn transactivates epidermal growth factor receptor, resulting in the assembly and activation of multiple signaling cascades such as the ERK1/2 2 and phospholipase C-␥/ protein kinase C pathways (5, 6) .
Because several laboratories have demonstrated that the activation of Src is essential for ouabain-induced changes in many cellular activities including the regulation of intracellular calcium, gene expression, and cell growth (6 -9), we have recently examined whether the Na/K-ATPase interacts directly with Src to form a functional signaling receptor (10) . Using in vitro glutathione S-transferase pulldown assays we have identified that the second and the third intracellular domains of the Na/K-ATPase ␣1 subunit interact with the Src SH2 and the kinase domains, respectively. Functionally these interactions keep Src in an inactive state, and binding of ouabain to this inactive Na/K-ATPase⅐Src complex frees and then activates the associated Src (10) . These new findings suggest that the cellular Src-interacting Na/K-ATPase may play an important role in regulation of the basal Src activity and serve as a functional receptor for ouabain to stimulate protein tyrosine phosphorylation in live cells. To test this hypothesis we have developed an siRNA-based assay that allows us to determine the effect of changes in the amount and properties of the Na/K-ATPase on both basal and ouabain-stimulated Src activity.
EXPERIMENTAL PROCEDURES
Materials-Chemicals of the highest purity were purchased from Sigma. The GeneSuppressor vector was purchased from BioCarta (San Diego, CA). Cell culture media, fetal bovine serum, trypsin, Lipofectamine 2000, and restriction enzymes were purchased from Invitrogen. EYFP expression vector (pEYFP) and ECFP expression vector (pECFP) were obtained from Clontech. QuikChange mutagenesis kit was purchased from Stratagene (La Jolla, CA). Optitran nitrocellulose membrane was from Schleicher & Schuell. Enhanced chemiluminescence SuperSignal kit was purchased from Pierce. Image-iT FX signal enhancer, Antifade kit, Alexa Fluor 488-conjugated antimouse/rabbit IgG and Alexa Fluor 546-conjugated anti-mouse/ rabbit IgG antibodies were obtained from Molecular Probes (Eugene, OR). Anti-Src (clone GD11) monoclonal antibody, anti-Na/K-ATPase ␣1 polyclonal and monoclonal (clone C464.6) antibodies, anti-phosphotyrosine (clone 4G10) antibody, and protein G-agarose were from Upstate Biotechnology Inc. (Lake Placid, NY). The polyclonal anti-Tyr(P) 418 -Src and anti-Tyr(P) 529 -Src antibodies were from BIOSOURCE (Camarillo, CA). The polyclonal anti-FAK and anti-Tyr(P) 925 -FAK antibodies were from Cell Signaling (Danvers, MA). The monoclonal anti-␣1 antibody (␣6F) was obtained from the Developmental Studies Hybridoma Bank at the University of Iowa. Anti-c-Src (B-12) monoclonal antibody, anti-c-Src (SRC2) polyclonal antibody, anti-ERK (C-16) polyclonal antibody, anti-pERK (E-4) monoclonal antibody, and all the secondary horseradish peroxidase-conjugated antibodies were from Santa Cruz Biotechnology Inc. (Santa Cruz, CA). Polyclonal rat ␣1-specific antibody (anti-NASE) was provided by Dr. Thomas Pressley (Texas Tech University, Lubbock, TX).
Cell Culture-LLC-PK1 cells and human embryonic kidney 293T cells were obtained from American Type Culture Collection and maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, 100 units/ml penicillin, and 100 g/ml streptomycin in a 5% CO 2 -humidified incubator as described previously (10, 11) .
Construction of the siRNA Expression Vectors-siRNAs were constructed using the GeneSuppressor construction kit as described previously (11) . Briefly four pairs of oligonucleotides (A1-A4) were synthesized using the human ␣1 cDNA (GenBank TM accession number NM_000701) as template (see Table 1 for details), and the inserts were prepared by annealing two complementary oligonucleotides. The annealed inserts were then cloned into pSuppressor TM -U6 vector digested with SalI and XbaI. Positive clones were confirmed by nucleotide sequencing.
Site-directed Mutagenesis-Rat ␣1 expression vector pRc/ CMV-␣1AAC was provided by Dr. Pressley (12) . To make the expression of rat ␣1 insensitive to A4 siRNA, the ␣1 siRNAtargeted sequence was silently mutated from 2530 ggtcgtctgatcttt (GenBank TM accession number NM_012504) to 2530 ggcaggctaatattc using the QuikChange mutagenesis kit. The SspI (aat/att) restriction site was generated to facilitate the clone screening. The positive mutant (pRc/CMV-␣1AACm1 or AAC in short) was verified by DNA sequencing and then used in this study. The pumping-null mutant (D371E) was generated by mutating the 1126 gacaag to 1126 gagaag using pRc/CMV␣1AACm1 as the template (13) .
Generation of Stable ␣1 Subunit Knockdown and Knock-in Cell Lines-Human embryonic kidney 293T cells were transiently transfected with different siRNA expression vectors along with pEYFP using Lipofectamine 2000 as we described previously (11) . After 48 h, cells were first examined for the expression of EYFP for assessing the transfection efficiency and then collected for analysis of endogenous ␣1 content by Western blot. To generate stable cell lines, one batch of LLC-PK1 cells was transfected with the A4 siRNA expression vector (pSuppressor-A4 siRNA) (Table 1 ) and a puromycin selection marker (pBade-puro). Another batch of cells was co-transfected with pEYFP together with the pSuppressor-A4 siRNA and pBade-puro so that the co-expressed EYFP could be used as a marker to pick clones. Empty vector (pSuppressor) or A1 siRNA-transfected cells were co-selected and used as a control. The cells were selected with puromycin (1 g/ml) 24 h posttransfection. Puromycin-resistant colonies were cloned and expanded. To rescue the Na/K-ATPase knockdown cells, cells were transfected with the pRc/CMV-␣1AACm1. Selection was initiated with 3 M ouabain because untransfected cells were very sensitive to ouabain. After about 1 week, ouabain-resistant colonies were isolated and expanded into stable cell lines in the absence of ouabain. G418 was not used because these cells are resistant to it, requiring more than 3 mg/ml to kill the untransfected cells. The knockdown cells were also sensitive to blasticidin (15 g/ml), and we have recently used this agent for other selections.
Immunoprecipitation and Immunoblot Analysis-Cells were washed with PBS, solubilized in modified ice-cold radioimmune precipitation assay buffer, and subjected to immunoprecipitation or Western blot analysis as described previously (11) . Protein signal was detected using the enhanced chemiluminescence kit and quantified using a Bio-Rad GS-670 imaging densitometer.
Na/K-ATPase Activity Assay-Na/K-ATPase enzymatic activity was determined as we described previously (14) . Briefly cells were collected from the cultures in Tris-EGTA buffer (pH 7.2) and briefly sonicated. The cell lysates were then treated with alamethicin at a concentration of 0.1 mg/mg of protein for 30 min at room temperature. ATPase activity was measured by the determination of the initial release of 32 P from [␥-
32
P]ATP, and the reaction was carried out in a reaction mixture (1 ml) containing 100 mM NaCl, 25 mM KCl, 3 mM MgCl 2 , 1 mM EGTA, 2 mM ATP, 5 mM NaN 3 , and 50 mM Tris-HCl (pH 7.4). Na/KATPase activity was calculated as the difference between the activities measured in the absence of ouabain and in the presence of 1 mM ouabain. To determine the ouabain concentration curve, the alamethicin-treated cell lysates were preincubated with different concentrations of ouabain for 15 min before ATP was added to start the reaction.
Confocal Fluorescence Microscopy-Cells cultured on coverslips were washed twice with PBS and fixed for 15 min with methanol prechilled at Ϫ20°C. The fixed cells were then rinsed with PBS three times and blocked with 200 l of Image-iT FX signal enhancer for 30 min at room temperature. The cells were washed again and incubated with the primary antibodies in PBS containing 1% bovine serum albumin for 1 h at room temperature. After three washes with PBS, the cells were incubated with corresponding Alexa Fluor-conjugated secondary antibodies. Image visualization was performed using a Leica DMIRE2 confocal microscope (Leica, Mannheim, Germany). Leica confocal software was used for data analysis.
FRET Analysis by Acceptor Photobleaching-ECFP was fused to the C terminus of Src, and EYFP was fused to the N terminus of rat Na/K-ATPase ␣1 subunit or its mutant. FRET analysis was performed in cells co-transfected with Src-ECFP and EYFP-rat ␣1 expression vectors using the acceptor photobleaching protocol as we described previously (10) . Briefly after 24 h culture, cells on a glass coverslip were fixed with methanol prechilled at Ϫ20°C for 15 min and washed twice with PBS solution. The EYFP-rat ␣1 was photobleached by applying a high intensity 515 nM laser, and the emission of ECFP excited by 456 nM laser was recorded before (D pre ) and after (D post ) EYFP photobleaching. The FRET efficiency was then calculated by the ratio of (D post -D pre )/D pre . Cells transfected with either Src-ECFP and EYFP or EYFP-␣1 and ECFP expression vectors were used as a control, and no detectable FRET was observed in these control cells.
Data Analysis-Data are given as mean Ϯ S.E. Statistical analysis was performed using the Student's t test, and significance was accepted at p Ͻ 0.05. Table 1 , a total of four pairs of the ␣1-specific siRNAs was selected based on the strategy we used previously (11) . Transient transfection assay in human embryonic kidney 293T cells showed that expression of A4 siRNA resulted in over 40% decreases in the expression of the human ␣1 subunit, whereas others gave 0 (A1 siRNA) to 20% (A2 and A3 siRNAs) reduction. Because the transfection efficiency was about 50% as indicated by the co-expressed EYFP, we reasoned that A4 siRNA is effective in silencing the expression of endogenous Na/K-ATPase. Therefore, LLC-PK1 cells were transfected with A4 siRNA expression vector (pSuppressor-A4 siRNA) and a puromycin selection marker (pBade-puro) either with or without pEYFP as described under "Experimental Procedures." After two rounds of selection, we collected 20 stable transfectants. Western blot analysis using a monoclonal (␣6F) antibody showed that the expression of the ␣1 subunit in these clones was significantly reduced in comparison with the control P-11 cells that were transfected with empty vector (pSuppressor) and selected. In contrast, cell clones (e.g. A1) obtained from the LLC-PK1 cells that were transfected with A1 siRNA expressed ␣1 at a level comparable to that in P-11 cells (see Table 2 ). Therefore, we expanded and further characterized three A4 siRNA-expressing clones. As shown in Fig. 1A , expression of the ␣1 subunit was significantly reduced in A4-11, TCN23-19, and PY-17 cells. Of these cell lines, the PY-17 cells, which were cloned by using the co-expressed EYFP as a marker, expressed the lowest level of the Na/K-ATPase. Table 2 shows the quantitative data on the relative amount of the ␣1 in these and other cell lines we generated. Because control Western blot using purified Na/K-ATPase prepared from pig kidney showed that it was only possible to perform reasonable quantitative assay comparing two samples with less than 6-fold differences in the amount of ␣1 (data not shown), we measured the relative amount of ␣1 in these cells by comparing A4-11 with the control P-11 and then TCN23-19 and PY-17 with A4-11. To confirm the above Western blot data, we also probed the blots with a different anti-Na/K-ATPase ␣1 monoclonal antibody (clone C464.6) and an anti-Na/K-ATPase ␣1 polyclonal anti- Table 2 ). B, P-11 and PY-17 cells were mixed, co-cultured for 24 h, and then immunostained with anti-␣1 antibody (clone C464.6) as described under "Experimental Procedures." The scale bar represents 50 M. 19) 93.7 Ϯ 9.9 pSuppressor-A4 siRNA, pBade-puro, pEYFP, pRc/ CMV-␣1AACm1 (rat ␣1)
RESULTS

Manipulation of the Cellular Na/K-ATPase Content by siRNAbased Assays-As shown in
body, showing essentially the same results as in Fig. 1A . In addition, when co-cultured P-11 and PY-17 cells were immunostained using anti-Na/K-ATPase ␣1 antibody (clone C464.6), we found that the green PY-17 cells exhibited no detectable expression of the ␣1, whereas the plasma membrane of control P-11 cells was clearly labeled by the antibody (Fig. 1B) . To be sure that knockdown of the ␣1 subunit does not induce the expression of other isoforms, we analyzed the cell lysates for both ␣2 and ␣3 and found no detectable signals in the above cell lines. Finally when ouabain-sensitive ATPase activity was measured in the cell lysates, a significant (80%) reduction was noted in the PY-17 cells in comparison with the control P-11 cells (Table 3) . Because PY-17 cells have very low endogenous Na/KATPase, these cells will be very useful for studying the structure-function properties of the Na/K-ATPase if we can rescue the cells by knocking in an exogenous ␣1. To test this possibility, we first made silent mutations of the rat ␣1 cDNA to change the siRNA-targeted sequence. We then transfected PY-17 cells with the mutated rat ␣1 expression vector (pRc/CMV␣1AACm1) and generated several stable transfectants. Further analysis of the clone AAC-19 showed that these cells, unlike both P-11 and PY-17, expressed rat ␣1 ( Fig. 2A) . When the same blots were analyzed for total ␣1 using the monoclonal anti-␣1 antibody (␣6F), we found that AAC-19 cells expressed an amount of ␣1 comparable to that in control P-11 cells (Fig.  2A) . This result was further confirmed by immunostaining of the co-cultured P-11 and AAC-19 cells using anti-␣1 (clone C464.6) antibody. As depicted in Fig. 2B , the green AAC-19 and control P-11 cells exhibited similar levels of the Na/K-ATPase in the plasma membrane. Control experiments also demonstrated that the rat ␣1 was stably expressed in this cell line for at least 20 passages in the absence of ouabain. Functionally knock-in of the rat ␣1 into PY-17 cells was able to restore Na/KATPase activity (Table 3) . Most importantly, it shifted the doseresponse curve of ouabain on the ATPase activity and made the rescued cells less ouabain-sensitive. In fact, the rescued cells behave as rat cell lines (5) that express only the ␣1 isoform (Fig.  3) . It is important to note that PY-17 cells were as sensitive to ouabain as the control P-11 cells and that 10 M ouabain caused a complete inhibition of the Na/K-ATPase.
Regulation of Basal Src Activity by the Na/K-ATPase-Our in vitro studies have shown that the Na/K-ATPase directly binds and keeps Src in an inactive state. If this mode of regulation operates in live cells, we would expect that reduction of intracellular Na/K-ATPase will decrease the interaction, resulting in an increase in basal Src activity. To test this, we measured the phosphorylation of Src (Tyr (P) 418 -Src), indicative of Src activation (4, 10) , in the cell lysates from the above cell lines. As depicted in Fig. 4A , the expression of total Src was not altered by knockdown of the endogenous Na/K-ATPase. However, the levels of active Src were significantly increased in A4-11, TCN23-19, and PY-17 cells. Interestingly the increase in Src activity appeared to be inversely correlated with the amounts of Na/K-ATPase expressed in these cells (Fig. 4B ). These findings were further confirmed by immunostaining the cells with antiTyr(P) 418 -Src antibody, showing that TCN23-19 cells contained much more active Src than P-11 cells contained (Fig. 4C) . It is important to note that there was no difference in the amount of active Src between two control cell lines, P-11 and A1 cells (data not shown).
To test whether the increase in Src activity due to the decreased expression of the Na/K-ATPase is reversible upon repletion of the Na/K-ATPase, we determined the total Src and the active Src in AAC-19 cells. As depicted in Fig. 2 , AAC-19 cells were derived from the rat ␣1-transfected PY-17 cells and expressed an amount of the Na/K-ATPase comparable to that in control P-11 cells. Although knock-in of the rat ␣1 did not change the total Src in AAC-19 cells, it did reduce the level of the active Src to that seen in control P-11 cells (Fig. 5,  A and B) . As illustrated in Table 3 , the FIGURE 2. Expression of the Na/K-ATPase in AAC-19 cells. A, clone AAC-19 was generated by transfecting PY-17 cells with a rat ␣1-expressing vector as described under "Experimental Procedures." Cell lysates (15 g from P-11 and AAC-19 and 60 g from PY-17) were separated by SDS-PAGE and analyzed by Western blot. The blot was first probed with antibody ␣6F that recognizes both pig and rat ␣1 subunits, then striped, and reprobed with the anti-NASE that specifically reacts with rat ␣1. B, P-11 and AAC-19 cells were mixed, cocultured for 24 h, and immunostained with anti-␣1 antibody (clone C464.6) as described under "Experimental Procedures." The scale bar represents 50 M. Na/K-ATPase activity was reduced 80% in PY-17 cells. When intracellular Na ϩ was measured after the cells were incubated in 22 Na ϩ (0.5 Ci/ml) medium for 60 min to fully equilibrate exchangeable intracellular Na ϩ with 22 Na ϩ (15), we found that the steady state intracellular Na ϩ in PY-17 cells was about twice as much as in P-11 cells. 3 To be sure that changes in Src activity observed in AAC-19 cells are not due to the restoration of the functional Na/K-ATPase and subsequent decreases in intracellular Na ϩ , we tested whether knock-in of a pumping-null mutant of the rat ␣1 is sufficient for the observed interaction between the Na/K-ATPase and Src. PY-17 cells were transiently transfected with either silently mutated wild-type rat ␣1 (pRc/CMV␣1AACm1) or the rat ␣1 pumping-null mutant (D371E). As shown in Fig. 5C , expression of either rat ␣1 or the mutant reduced active Src in PY-17 cells. To further confirm these findings, we also transiently transfected TCN23-19 cells with the EYFP-fused rat ␣1 mutant expression vector (pEYFP-D371E) and immunostained for active Src. As depicted in Fig. 5D , the cells expressing the rat ␣1 mutant had much less active Src in comparison with the untransfected TCN23-19 cells. These data suggest that the pumping-null Na/K-ATPase mutant is still able to interact and regulate Src. To seek additional support for this notion, we also performed FRET analysis in TCN23-19 cells transiently transfected with EYFP-rat ␣1 mutant (D371E) and Src-ECFP expression vectors. As depicted in Fig. 6A , the pumping-null mutant was targeted to the plasma membrane. When FRET was measured in these transfected cells by acceptor photobleaching protocol, an energy transfer from Src-ECFP to EYFP-D371E was clearly demonstrated (Fig. 6B) . The FRET efficiency measured from a total of 20 cells in three separate experiments ranged from 10.4 to 15.6 (13.2 Ϯ 1.4). These data indicate that the pumping-null Na/K-ATPase acts like the wildtype ␣1 (10) and can interact with Src to form a signaling complex. This conclusion is further supported by the co-immunoprecipitation assay showing that the rat ␣1 mutant could be co-precipitated by anti-Src antibody (Fig. 6C) .
FAK is a known Src effector that plays an important role in regulation of cell migration and proliferation (16 -18) . Activation of Src stimulates phosphorylation of FAK Tyr 925 , which subsequently can lead to the activation of ERK1/2 (19, 20) . To examine whether an increase in basal Src activity can result in the activation of Src effectors, we measured tyrosine phosphorylation of FAK in ␣1 knockdown cells. As depicted in Fig. 7A , cell lysates were immunoprecipitated by an antiphosphotyrosine antibody, and the immunoprecipitates were probed by anti-FAK antibody. The data clearly showed that the ␣1 knockdown was capable of increasing the amounts of tyrosine-phosphorylated FAK. Specifically when cell lysates were probed for Tyr(P) 925 -FAK, we found a significant increase in Tyr(P) 925 -FAK in both A4-11 and PY-17 cells (Fig. 7B) . Interestingly when total ERK1/2 and pERK1/2 were measured, we found a modest increase in the amount of active ERK1/2 in PY-17 cells (Fig. 7C) . This is in accordance with the known function of Tyr(P) 925 -FAK (19, 20) . Significantly this increase in Tyr(P) 925 was sensitive to Src inhibitor PP2 (Fig. 7D) . It is important to note that the FAK phosphorylation correlated well to the levels of active Src in the PP2-treated knockdown cells. Taken together, these data indicate that the increased Src activity due to the ␣1 knockdown can stimulate tyrosine phosphorylation of Src effectors. This notion is further supported by the observation that expression of the pumping-null mutant (D371E) not only restored the basal Src activity but also reduced FAK Tyr 925 phosphorylation in PY-17 cells (Fig. 7E) .
Knockdown of the Na/K-ATPase Abolishes Ouabain-induced Activation of Src and ERK1/2-Because the Na/K-ATPase⅐Src complex serves as a functional receptor for ouabain to induce Src activation and subsequent stimulation of ERK1/2 (5, 10), the above findings prompted us to test whether knockdown of the Na/K-ATPase affects ouabain-activated signal transduction. As shown in Fig. 8A , although ouabain activated Src in P-11 cells as we reported previously (4, 5) , this effect of ouabain was essentially abolished in PY-17 cells, whereas a significant reduction was observed in A4-11 cells. To be sure that this inhibition is not due to nonspecific defects in receptor signal transduction, we also measured the effect of EGF on Src. We found that epidermal growth factor was able to stimulate SrcTyr(P) 418 in both P-11 and PY-17 cells (2.5 Ϯ 0.3-fold increase in P-11 versus 1.7 Ϯ 0.2-fold increase in PY-17, n ϭ 3). Consistent with the findings on Src, we also failed to detect any ouabain-induced change in ERK1/2 phosphorylation in PY-17 cells (Fig. 8B) . In contrast, epidermal growth factor was able to stimulate ERK1/2 in PY-17 cells (data not shown). These data support the notion that the Na/K-ATPase is indeed the receptor for ouabain-induced signal transduction. This notion is further supported by the findings presented in Fig. 8, C and D, showing that knock-in of the rat ␣1 not only restored the ouabain responses but also shifted the dose-response curve to the right in AAC-19 cells.
DISCUSSION
In this report we not only introduced an effective and ␣1-specific RNA interference assay but also provided a protocol for rescuing the Na/K-ATPase-depleted cells. These procedures have made it possible for us to demonstrate that the cellular Na/K-ATPase regulates Src and its effector FAK and that the Na/K-ATPase⅐Src complex serves as a sole receptor for ouabain to activate Src and subsequently ERK1/2 in live cells.
Manipulation of the Cellular Na/K-ATPase Content by RNA Interference Assays-RNA interference is a cellular mechanism that was first discovered in 1998 in Caenorhabditis elegans and refers to the post-transcriptional gene silencing by doublestranded RNA-triggered degradation of a homologous mRNA (21) . This has now been developed as a powerful tool for artificially silencing a specific gene in a variety of biological systems including cultured cells and whole organisms. Using the strategy developed by Paul et al. (22) and transient transfection assay, we identified that A4 siRNA was effective for silencing the ␣1 expression. Thus, we transfected pig LLC-PK1 cells with the A4 siRNA expression vector and cloned several stable cell lines. Western blot analysis and immunostaining assay showed that the expression of the ␣1 in the cloned cell lines was significantly reduced (Figs. 1 and 2 and Table 2 ). For example, the ␣1 in PY-17 cells is only about 8% of that in control P-11 cells. Functional analysis revealed that depletion of the ␣1 resulted in an 80% reduction in ouabain-sensitive ATPase activity in PY-17 cells (Table 3 ). Clearly we have developed an effective protocol for silencing the expression of endogenous ␣1 in cultured cells.
To test whether the ␣1-depleted cells can be used to study the signaling functions of an exogenous/mutant ␣1, we transfected PY-17 cells with a rat ␣1 expression vector in which A4 siRNAtargeted sequence was silently mutated. By taking advantage of the availability of an antibody that specifically reacts with rat ␣1, we FIGURE 6 . Interaction between Src and the pumping-null Na/K-ATPase. A and B, TCN23-19 cells were co-transfected with Src-ECFP and EYFP-rat ␣1 mutant (D371E) expression vectors. After 24 h, FRET analysis was performed as described under "Experimental Procedures." Boxed ROI_1 (green) was photobleached, and the ROI_3 (yellow) membrane area was analyzed for FRET. The boxed ROI_2 (purple) was selected and served as a non-bleaching control. The experiments were repeated three times, and a total of 20 cells were analyzed. C, TCN23-19 cells were transiently transfected as in A with either silently mutated wild-type rat ␣1 (AAC ) or rat ␣1 pumping-null mutant (D371E ) expression vectors. After 36 h, cell lysates were prepared and subjected to immunoprecipitation using monoclonal anti-Src (clone GD11) antibody. Immunoprecipitates were then analyzed by Western blot using either anti-NASE antibody (for rat ␣1) or anti-c-Src (SRC2) antibody. The same experiments were repeated three times, and a representative Western blot is shown. IP, immunoprecipitate.
demonstrated that the exogenous rat ␣1 could be knocked in and that the expression of rat ␣1 restored not only the total cellular Na/K-ATPase protein but also the Na/K-ATPase activity. Importantly the rat ␣1-rescued cells (AAC-19) exhibited the same ouabain sensitivity as the rat cell lines that only express the Na/K-ATPase ␣1 subunit (Fig. 3) . Taken together, the data indicate that we have developed an effective protocol for manipulating cellular Na/K-ATPase. It is important to note that this protocol offers additional advantages over the widely used ouabain selection protocol for expression of mutated Na/KATPase in ouabain-sensitive cell lines (23) (24) (25) (26) . First, our protocol makes it possible to deplete endogenous Na/K-ATPase, allowing the investigators to study the effects of decreases in Na/K-ATPase expression on cellular function. Second, it does not require using ouabain to force the expression of the transfected Na/KATPase. This is important in view of recent studies showing that ouabain stimulates the signaling function of the Na/K-ATPase and induces the endocytosis of the enzyme (4, 9, 27, 28) . Third, this protocol allows us to study the exogenous/mutant Na/KATPase in the cells that have very low (less than 10%) endogenous Na/KATPase. Fourth, the identified A4 siRNA should be effective in silencing the ␣1 expression in cells derived from species other than human and pig because the human ␣1 cDNA sequence (nucleotide 2293 to nucleotide 2312) targeted by A4 siRNA is conserved among all identified ␣1 subunits (but not other isoforms) from fish to human. Finally rescuing PY-17 cells with different isoforms of the Na/K-ATPase would make it possible for us to uncover the potential isoform-specific signaling functions.
A Pool of Src-interacting Na/K-ATPase-Recently we have shown that the Na/K-ATPase resides in caveolae with Src (11, 29) . FRET analysis indicates that the signaling Na/K-ATPase and Src are likely to interact and form a functional receptor complex. In vitro binding assay demonstrates that the ␣1 subunit and FIGURE 7. Regulation of FAK phosphorylation by Src-interacting Na/K-ATPase. A, cultured P-11 and PY-17 cells were serum-starved for 12 h. Cell lysates were then immunoprecipitated using anti-phosphotyrosine antibody (4G10), and immunoprecipitates were analyzed by anti-FAK antibody. The combined quantitative data were from three independent experiments. B, cell lysates from different cell lines were separated by SDS-PAGE and analyzed by anti-Tyr(P) 925 -FAK and anti-Tyr(P) 418 -Src antibodies. The same membrane was striped and reprobed with anti-c-Src (B-12) antibody. A representative blot of three independent experiments is shown. C, cell lysates were analyzed by anti-pERK1/2 or anti-ERK1/2 antibody. The quantitative data (mean Ϯ S.E.) were calculated from four separate experiments as relative ratio of pERK/ERK. D, P-11 and PY-17 cells were treated with 1 M PP2 for 0.5 and 2 h. FAK and Src activation was measured by using the specific antibodies. A representative Western blot is shown, and the same experiments were repeated three times. E, PY-17 cells were transiently transfected with either an empty vector (mock) or the D371E mutant. After 36 h, the transfected cells were lysed and analyzed by Western blot using specific antibodies as indicated. A representative Western blot is shown, and the same experiments were repeated three times. IP, immunoprecipitate; IB, immunoblot. *, p Ͻ 0.05 versus P-11.
Src can interact directly via multiple domains and that the interaction keeps Src in an inactive state (10) . These findings led us to propose that there may be a Src-interacting pool of Na/K-ATPase that not only regulates the basal Src activity but also serves as a receptor for ouabain to stimulate Src-dependent tyrosine phosphorylation of multiple effectors. The data presented here provide further support to this hypothesis. First, because the signaling Na/K-ATPase binds and keeps Src in an inactive state (10), we expected that reduction of the endogenous Na/K-ATPase would deplete the Src-interacting pool of Na/K-ATPase, thus resulting in the Src activation. Indeed as shown in Fig. 4 , the ␣1 knockdown cells contain more active Src than the control P-11 cells. It is important to mention that the ␣1 knockdown did cause a significant increase in intracellular Na ϩ concentration in PY-17 cells. However, when intracellular Ca 2ϩ was measured by fura-2 as we described previously (30) , the steady state Ca 2ϩ in PY-17 cells was comparable to that in P-11 cells. 3 Thus, it is unlikely that increases in Src activity are due to changes in intracellular Na ϩ or Ca 2ϩ . Second, when the ␣1 knockdown PY-17 cells were rescued by the rat ␣1, we observed that the knock-in of the rat ␣1 was sufficient to replete the pool of Src-interacting Na/K-ATPase, leading to the restoration of basal Src activity. Finally because our in vitro bind- ing assay showed that the third intracellular domain of the ␣1 interacts and inhibits Src activity (10), we expected that a pumping-null mutant of the rat ␣1 should be able to bind and inhibit Src in live cells. Indeed we found that knock-in of rat ␣1 mutant D371E into PY-17 cells was also able to replete this Src-interacting pool of Na/K-ATPase and reduce the amount of active Src (Fig. 5) . In addition, both FRET analysis and co-immunoprecipitation assay showed that the pumping-null mutant could interact with Src in live cells (Fig. 6) . Because expression of the pumping-null mutant would not reduce intracellular Na ϩ concentration in PY-17 cells, these data also indicate that the Na/K-ATPase can interact and regulate Src independently of changes in intracellular Na ϩ concentration.
FAK is involved in regulation of cell proliferation, cell survival, and cell migration (16 -18) . It is also one of the effectors of Src. Binding of active Src to FAK leads to full activation of FAK and tyrosine phosphorylation of FAK Tyr 925 , which results in the assembly of several downstream signaling modules including the activation of ERK1/2. Interestingly we found that depletion of cellular Na/K-ATPase not only activated Src but also stimulated tyrosine phosphorylation of FAK. Inhibition of Src by either PP2 or knock-in of a pump-null ␣1 mutant reduced Tyr(P) 925 -FAK in PY-17 cells (Fig. 7) . Consistently we have also observed that ouabain stimulated Src and subsequently FAK in the control LLC-PK1 cells. 4 These findings are significant. First, they support the notion that the Na/KATPase is an important regulator of protein kinases. Second, the regulatory effects of the Na/K-ATPase on Src and Src effector FAK depend on the ability of the Na/K-ATPase to interact with proteins, but not to pump ions. Third, the ␣1 depletioninduced Src activation is capable of generating downstream pathways. To this end, it is worth noting that FAK plays a key role in regulation of cell motility. It has been reported that depletion of ␤1 in epithelial cells affects the formation of tight junctions and cell motility (31, 32) . Thus, it will be of interest to further test the role of ␣1 depletion and subsequent activation of FAK in the regulation of cell migration.
We showed previously that ouabain-induced signal transduction appears to be initiated by the activation of Src (4). Because ouabain uses the Na/K-ATPase⅐Src complex as a functional receptor, we expected that the ouabain-induced activation of Src should correlate with the size of the pool of Srcinteracting Na/K-ATPase. Indeed we found that the effect of ouabain on Src activation correlated inversely with cellular levels of the Na/K-ATPase. Although ouabain induced a modest activation of Src in A4-11 cells, it failed to activate Src in PY-17 cells. Because Src is required to transmit the ouabain signal to many downstream effectors (5, 10, 11) , the new findings support the notion that the Na/K-ATPase⅐Src complex is the sole receptor for ouabain to provoke the protein kinase cascades. This notion is further supported by the following observations. First, rescuing PY-17 cells with the rat ␣1 restored the effect of ouabain on Src and ERK1/2. Second, because the rescued cells expressed the ouabain-insensitive rat ␣1, a much higher ouabain concentration was required to stimulate Src and subsequently ERK1/2 in AAC-19 cells (Fig. 8) .
In short, we have developed a powerful protocol for manipulating the cellular Na/K-ATPase that has allowed us to further characterize the signaling properties of the Na/K-ATPase. In addition, these new findings support the hypothesis that the Na/KATPase is an important receptor capable of transmitting ouabain signals via protein kinases (4, 5, 9, 33, 34) . Finally because Src is actively involved in control of cell growth (35) , our new findings warrant the need for re-examining the issue of whether the Na/KATPase-mediated repression of Src and ouabain-provoked activation of Src play a role in cancer biology.
